Trial Profile
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction: An Intracoronary Optical Coherence Tomography Randomized Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms COVER-AMI
- 18 Dec 2018 Status changed from recruiting to completed.
- 31 May 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 26 Sep 2016 New trial record